CA1113396A - Iontophoretic medicinal treatments of mammalian bodies and articles therefor - Google Patents
Iontophoretic medicinal treatments of mammalian bodies and articles thereforInfo
- Publication number
- CA1113396A CA1113396A CA282,068A CA282068A CA1113396A CA 1113396 A CA1113396 A CA 1113396A CA 282068 A CA282068 A CA 282068A CA 1113396 A CA1113396 A CA 1113396A
- Authority
- CA
- Canada
- Prior art keywords
- bandage
- electrode
- medicament
- collagen
- collagen fibrils
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000011282 treatment Methods 0.000 title description 14
- 102000008186 Collagen Human genes 0.000 claims abstract description 84
- 108010035532 Collagen Proteins 0.000 claims abstract description 84
- 229920001436 collagen Polymers 0.000 claims abstract description 84
- 239000003814 drug Substances 0.000 claims abstract description 83
- 239000000758 substrate Substances 0.000 claims abstract description 32
- 230000003902 lesion Effects 0.000 claims abstract description 25
- 239000003792 electrolyte Substances 0.000 claims abstract description 11
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical group [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 34
- 229910052782 aluminium Inorganic materials 0.000 claims description 27
- 239000011888 foil Substances 0.000 claims description 26
- 239000006185 dispersion Substances 0.000 claims description 24
- 108700009872 mild silver Proteins 0.000 claims description 23
- 229940037310 mild silver protein Drugs 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 15
- 229910052751 metal Inorganic materials 0.000 claims description 14
- 239000002184 metal Substances 0.000 claims description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 13
- 239000012528 membrane Substances 0.000 claims description 13
- 230000001464 adherent effect Effects 0.000 claims description 12
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 10
- 230000001681 protective effect Effects 0.000 claims description 10
- 229910052709 silver Inorganic materials 0.000 claims description 10
- 239000004332 silver Substances 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 5
- 239000004744 fabric Substances 0.000 claims description 5
- 239000000017 hydrogel Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229910052719 titanium Inorganic materials 0.000 claims description 5
- 239000010936 titanium Substances 0.000 claims description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 4
- 229910052718 tin Inorganic materials 0.000 claims description 4
- 239000011135 tin Substances 0.000 claims description 4
- 230000005012 migration Effects 0.000 claims description 2
- 238000013508 migration Methods 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims description 2
- 235000011164 potassium chloride Nutrition 0.000 claims description 2
- 239000001103 potassium chloride Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims 4
- 239000003973 paint Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 210000001124 body fluid Anatomy 0.000 abstract description 5
- 239000010839 body fluid Substances 0.000 abstract description 5
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 33
- 208000027418 Wounds and injury Diseases 0.000 description 33
- 239000000463 material Substances 0.000 description 19
- 230000005684 electric field Effects 0.000 description 16
- 239000007772 electrode material Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 8
- 239000000853 adhesive Substances 0.000 description 8
- 230000001070 adhesive effect Effects 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 230000035876 healing Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000011253 protective coating Substances 0.000 description 4
- 235000004252 protein component Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010027439 Metal poisoning Diseases 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 239000011262 electrochemically active material Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108090000270 Ficain Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 108010082714 Silver Proteins Proteins 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- MLIREBYILWEBDM-UHFFFAOYSA-N cyanoacetic acid Chemical compound OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- POTUGHMKJGOKRI-UHFFFAOYSA-N ficin Chemical compound FI=CI=N POTUGHMKJGOKRI-UHFFFAOYSA-N 0.000 description 2
- 235000019836 ficin Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000009940 knitting Methods 0.000 description 2
- 239000007769 metal material Substances 0.000 description 2
- 150000001455 metallic ions Chemical class 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 108700024661 strong silver Proteins 0.000 description 2
- -1 such as Inorganic materials 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229910052715 tantalum Inorganic materials 0.000 description 2
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 229930183010 Amphotericin Natural products 0.000 description 1
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 101100536354 Drosophila melanogaster tant gene Proteins 0.000 description 1
- POPFMWWJOGLOIF-XWCQMRHXSA-N Flurandrenolide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O POPFMWWJOGLOIF-XWCQMRHXSA-N 0.000 description 1
- FQISKWAFAHGMGT-SGJOWKDISA-M Methylprednisolone sodium succinate Chemical compound [Na+].C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(=O)CCC([O-])=O)CC[C@H]21 FQISKWAFAHGMGT-SGJOWKDISA-M 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- 241000011102 Thera Species 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940009444 amphotericin Drugs 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 229960002344 dexamethasone sodium phosphate Drugs 0.000 description 1
- PLCQGRYPOISRTQ-FCJDYXGNSA-L dexamethasone sodium phosphate Chemical compound [Na+].[Na+].C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)COP([O-])([O-])=O)(O)[C@@]1(C)C[C@@H]2O PLCQGRYPOISRTQ-FCJDYXGNSA-L 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229960004511 fludroxycortide Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- ATADHKWKHYVBTJ-UHFFFAOYSA-N hydron;4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol;chloride Chemical compound Cl.CNCC(O)C1=CC=C(O)C(O)=C1 ATADHKWKHYVBTJ-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 238000013187 longer-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229940086735 succinate Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Electrotherapy Devices (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75877477A | 1977-01-12 | 1977-01-12 | |
| US758,774 | 1985-07-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1113396A true CA1113396A (en) | 1981-12-01 |
Family
ID=25053063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA282,068A Expired CA1113396A (en) | 1977-01-12 | 1977-07-05 | Iontophoretic medicinal treatments of mammalian bodies and articles therefor |
Country Status (7)
| Country | Link |
|---|---|
| JP (1) | JPS5389295A (enrdf_load_stackoverflow) |
| AT (1) | AT367300B (enrdf_load_stackoverflow) |
| BE (1) | BE856603A (enrdf_load_stackoverflow) |
| CA (1) | CA1113396A (enrdf_load_stackoverflow) |
| DE (1) | DE2730990A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2377204A1 (enrdf_load_stackoverflow) |
| NL (1) | NL7707627A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8118857B2 (en) * | 2007-11-29 | 2012-02-21 | Boston Scientific Corporation | Medical articles that stimulate endothelial cell migration |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60203270A (ja) * | 1984-03-27 | 1985-10-14 | 鈴木 茂樹 | 薬物の経皮投与装置 |
| AU4198785A (en) * | 1984-05-07 | 1985-11-14 | Lloyd A. Ferreira | Conductive material and biomedical electrode |
| DE4114677A1 (de) * | 1990-10-10 | 1992-02-27 | Mario Bergner | Applikationsanordnung verschiedener elektrisch verbundener metalle am menschlichen koerper zu einem bioelektrischen system im sinne der elektrochemischen spannungsreihe mit spannungserhoehung bei moeglicher verwendung handelsueblicher ekg-elektrodenpflaster |
| DE4203898C2 (de) * | 1991-05-06 | 1993-11-25 | Mario Bergner | Pflasteranordnung zur galvanischen Behandlung |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1570570A (enrdf_load_stackoverflow) * | 1968-03-28 | 1969-06-13 | ||
| FR2263792A1 (en) * | 1974-03-12 | 1975-10-10 | Bondivenne Jean | Ionotherapy current generator - comprises thin flexible bag giving percutaneous medicament penetration |
-
1977
- 1977-07-05 CA CA282,068A patent/CA1113396A/en not_active Expired
- 1977-07-08 NL NL7707627A patent/NL7707627A/xx not_active Application Discontinuation
- 1977-07-08 FR FR7721165A patent/FR2377204A1/fr active Granted
- 1977-07-08 DE DE19772730990 patent/DE2730990A1/de not_active Withdrawn
- 1977-07-08 BE BE2056071A patent/BE856603A/xx not_active IP Right Cessation
- 1977-07-11 JP JP8207577A patent/JPS5389295A/ja active Pending
- 1977-07-11 AT AT0496977A patent/AT367300B/de not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8118857B2 (en) * | 2007-11-29 | 2012-02-21 | Boston Scientific Corporation | Medical articles that stimulate endothelial cell migration |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5389295A (en) | 1978-08-05 |
| FR2377204B1 (enrdf_load_stackoverflow) | 1981-05-08 |
| ATA496977A (de) | 1981-11-15 |
| NL7707627A (nl) | 1978-07-14 |
| DE2730990A1 (de) | 1978-07-13 |
| AT367300B (de) | 1982-06-25 |
| BE856603A (fr) | 1977-10-31 |
| FR2377204A1 (fr) | 1978-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4034750A (en) | Electrochemically linking collagen fibrils to animal tissue | |
| US4767401A (en) | Iontophoretic administration of ionizable or polar medicaments to a mammalian body | |
| AU2014260424C1 (en) | Expandable wound dressings | |
| US20090221985A1 (en) | System for iontophoretic transdermal delivery of polymeric agents and methods of use thereof | |
| EP0612258B1 (en) | Drug delivery device | |
| CA1317879C (en) | Electrolytic transdermal delivery of polypeptides | |
| CA2356197C (en) | Thin polymer film drug reservoirs | |
| JP4183909B2 (ja) | 電解経皮配布装置のための無水薬物貯蔵部 | |
| US5336168A (en) | Pulsating transdermal drug delivery system | |
| Chien et al. | Facilitated transdermal delivery of therapeutic peptides and proteins by iontophoretic delivery devices | |
| US5894021A (en) | Iontophoretic transdermal drug-delivery interface and skin treatment agent and treatment method using the same | |
| EP0429842A2 (en) | Device for the transdermal administration of protein or peptide drug | |
| US8295924B2 (en) | Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions | |
| CA2217014A1 (en) | Iontophoretic transdermal system for the administration of at least two substances | |
| GB1588933A (en) | Dressings for use on a mammalian body and capable of forming a galvanic couple therewith | |
| CA1113396A (en) | Iontophoretic medicinal treatments of mammalian bodies and articles therefor | |
| JP2909483B2 (ja) | イオントフォレーシス用皮膚処理剤 | |
| JPH1149659A (ja) | 絹フィブロインを含む皮膚塗布剤 | |
| JP2002345977A (ja) | イオン導入具 | |
| JP4171630B2 (ja) | イオン導入具 | |
| KR930003115B1 (ko) | 인슐린의 경피투여기구 | |
| Smyth | Investigation into the mechanism of action and chemical enhancement of transdermal iontophoreses of LHRH | |
| CA2190370C (en) | Composition and method for enhancing transdermal electrotransport agent delivery | |
| IE68757B1 (en) | Drug delivery device | |
| HK1032548B (en) | Anhydrous drug reservoir for electrolytic transdermal delivery device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |